ArticlePloS one2017

Outcomes and prognoses of patients with ovarian cancer using bevacizumab: 6-year experience in a tertiary care hospital of northern Taiwan.

Wei-Chun Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.